News | August 12, 2025
Cohance to invest Rs. 23 crore on cGMP Oligonucleotide facility at Hyderabad
This strategic investment strengthens Cohance's integrated oligonucleotide platform
This strategic investment strengthens Cohance's integrated oligonucleotide platform
Cupid reported total income of Rs. 64.75 crore in Q1 FY26 as compared to Rs. 44.03 crore in Q1 Fy25
Hikal has reported total income of Rs. 381.4 crores during the period ended June 30, 2025
Currently focused on platform-related queries, elva.AI is the first step in ekincare’s broader roadmap
IOLCP has reported total income of Rs. 559.06 crores during the period ended June 30, 2025
The facility includes advanced laboratories to monitor market trends, consumer needs, product innovation, and formulation improvements
Our specialty chemical businesses have continued to perform strongly, growing double digit YoY
The savings will be fully reinvested to support new product launches and its pipeline across multiple therapeutic areas
The latest BioE3 policy builds the framework for high-performance biomanufacturing to propel the development and production
Singhal brings a powerful blend of operational excellence, investor acumen, and visionary thinking
Subscribe To Our Newsletter & Stay Updated
